Medical Point İzmir Hospital hosted a highly significant vision meeting, bringing together the worlds of healthcare and science. Held on June 9, 2026, the event titled “Processes, Barriers, and Opportunities in Clinical Research” thoroughly addressed the future of the clinical research ecosystem in Turkey.
The event, held at the Medical Point İzmir Hospital Ata Hall, brought together prestigious names in medicine, including Prof. Dr. Aydın Erenmemişoğlu and Prof. Dr. Kaan Kavaklı, along with representatives from Kal-Der (Turkish Quality Association), the Clinical Research Association, and EGEDER (Aegean Medical Device Manufacturers and Suppliers Association), as well as numerous healthcare professionals.
Stakeholders of the Sector United Under One Roof
The panel focused heavily on the operational and bureaucratic challenges faced in clinical trial workflows, while shedding light on the massive global opportunities Turkey could seize in this field. The absolute necessity of robust inter-institutional collaborations was strongly emphasized. During his presentation, Prof. Dr. Aydın Erenmemişoğlu highlighted current clinical processes and future strategies, subsequently engaging in a lively, interactive Q&A session with the audience. Prof. Dr. Kaan Kavaklı and the accompanying association representatives also shared invaluable insights regarding the enhancement of quality standards in clinical trials and the strategic integration of domestic medical device manufacturing into active research pipelines.
Full Marks for the Phase 1 and R&D Centers
Following the highly attended panel program, Prof. Dr. Aydın Erenmemişoğlu and Prof. Dr. Kaan Kavaklı visited the Phase 1 Clinical Research Center and the R&D Center operating within Medical Point İzmir Hospital.
Examining the innovative projects, cutting-edge technological infrastructure, and laboratory capabilities firsthand, the esteemed professors highly praised Medical Point İzmir’s research capacity and operational standards. They noted that these Phase 1 and R&D centers hold strategic importance in accelerating Turkey’s vision for developing novel molecules and indigenous healthcare technologies.
With this high-level gathering and its state-of-the-art research infrastructure, Medical Point İzmir Hospital resolutely continues its mission to serve as a leading vanguard in both national and international clinical research.
